BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7122258)

  • 1. Gamma fetal antigen in spontaneous and carcinogen-induced rodent tumors. Survey of sarcomas and hepatic carcinomas.
    Higgins PJ
    Oncodev Biol Med; 1982; 3(2-3):91-6. PubMed ID: 7122258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive growth of transplanted tumors is accompanied by increasing serum concentrations of murine gamma fetal antigen.
    Higgins PJ; Marucs S; Hawrylko E
    Oncodev Biol Med; 1981; 2(1-2):77-87. PubMed ID: 6795603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of anti-gamma-FA-reactive antigens in spontaneous and carcinogen-induced malignancies of experimental animals.
    Higgins PJ; Tong C; Borenfreund E
    Oncology; 1981; 38(6):340-5. PubMed ID: 6170920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of murine gamma fetal antigen in adult hematopoietic tissue and during induced differentiation of Friend erythroleukemia cells.
    Higgins PJ; Silverstone AE; Bueti C; Pizzi VF; Melamed MR; Lipkin M; Traganos F
    J Natl Cancer Inst; 1986 May; 76(5):885-93. PubMed ID: 3457976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of immunosuppression on the induction and immunogenicity of chemically induced sarcomas.
    Fisher JC; Davis RC; Mannick JA
    Surgery; 1970 Jul; 68(1):150-6; discussion 156-7. PubMed ID: 10483462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Properties of a M(r) 110,000 tumor rejection antigen of the chemically induced BALB/c Meth A sarcoma.
    De Leo AB; Becker M; Lu L; Law LW
    Cancer Res; 1993 Apr; 53(7):1602-7. PubMed ID: 7680955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of suppressor cell activity in the spleens of mice with radiation-induced osteogenic sarcomas.
    Argyris BF; Reif AE
    Cancer Res; 1981 Mar; 41(3):839-44. PubMed ID: 6450637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune selection in murine tumors. Ph.d thesis.
    Svane IM; Engel AM
    APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The isolation and characterization of tumor-specific antigens of rodent and human tumors.
    Thomson DM; Gold P; Freedman SO; Shuster J
    Cancer Res; 1976 Sep; 36(9 PT 2):3518-25. PubMed ID: 975111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The soluble antigens of BALB/c sarcoma Meth-A: a relationship between a serologically defined tumor-specific surface antigen (TSSA) and the tumor-associated transplantation antigen (TATA).
    DuBois GC; Appella E; Law LW; DeLeo AB; Old LJ
    Transplant Proc; 1981 Dec; 13(4):1765-73. PubMed ID: 6173944
    [No Abstract]   [Full Text] [Related]  

  • 11. Inducing oral immune regulation of hepatitis B virus envelope proteins suppresses the growth of hepatocellular carcinoma in mice.
    Gotsman I; Alper R; Klein A; Rabbani E; Engelhardt D; Ilan Y
    Cancer; 2002 Jan; 94(2):406-14. PubMed ID: 11900226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenic properties of soluble cytosol fractions on Meth A sarcoma cells.
    DuBois GC; Appella E; Law LW; DeLeo AB; Old LJ
    Cancer Res; 1980 Nov; 40(11):4204-8. PubMed ID: 7471061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consistent fluctuations in quantities of circulating immune complexes during progressive and regressive phases of tumor growth.
    Jennette JC
    Am J Pathol; 1980 Aug; 100(2):403-10. PubMed ID: 7406017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two distinct pathways of immuno-modulation improve potency of p53 immunization in rejecting established tumors.
    Daftarian P; Song GY; Ali S; Faynsod M; Longmate J; Diamond DJ; Ellenhorn JD
    Cancer Res; 2004 Aug; 64(15):5407-14. PubMed ID: 15289349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of modified tumor antigen on experimentally induced sarcomas.
    Nigam SK; Bhatt VH
    Saudi Med J; 2001 Feb; 22(2):157-63. PubMed ID: 11299413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-associated blocking factors: isolation from sera of tumor-bearing mice.
    Tamerius J; Nepom J; Hellström I; Hellström KE
    J Immunol; 1976 Mar; 116(3):724-30. PubMed ID: 1254951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-dependent induction of hepatic tumor regression by the tissue microenvironment after transplantation of neoplastically transformed rat liver epithelial cells into the liver.
    McCullough KD; Coleman WB; Smith GJ; Grisham JW
    Cancer Res; 1997 May; 57(9):1807-13. PubMed ID: 9135026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of levamisole on methylcholanthrene-induced tumor. I. Its antitumor effect and immunological mechanism].
    Gomi K; Morimoto M; Nomoto K
    Gan To Kagaku Ryoho; 1982 Jul; 9(7):1262-8. PubMed ID: 7184454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential recognition of murine tumor-associated oncofetal transplantation antigen and individually specific tumor transplantation antigens by syngeneic cloned BALB/c and RFM mouse T cells.
    Rohrer JW; Rohrer SD; Barsoum A; Coggin JH
    J Immunol; 1994 Jan; 152(2):754-64. PubMed ID: 7904290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.